Company news

Sutro Biopharma, Inc. news in 2023

Sutro Biopharma, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (luvelta) in Pediatric Patients with Relapsed/Refractory CBF/GLIS Presented at ASH 2023

December 10, 2023

Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer

November 20, 2023

Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones

November 12, 2023

Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023

October 21, 2023

Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference

October 15, 2023

Sutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief Scientific Officer

September 18, 2023

Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones

August 9, 2023

Sutro Biopharma and Blackstone Announce Royalty Financing Collaboration

June 25, 2023

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

June 2, 2023

Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones

May 14, 2023

Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer

April 26, 2023

Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones

March 29, 2023

Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer

February 27, 2023

Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer

January 8, 2023

Decks in 2023